Peters GJ - Search Results

1

Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase.

Sigmond J, Bergman AM, Leon LG, Loves WJ, Hoebe EK, Peters GJ. Sigmond J, et al. Among authors: peters gj. Anticancer Drugs. 2010 Jul;21(6):591-9. doi: 10.1097/CAD.0b013e32833a3543. Anticancer Drugs. 2010. PMID: 20436341

2

Concentration and time dependent growth inhibition and metabolism in vitro by 2',2'-difluoro-deoxycytidine (gemcitabine).

Ruiz van Haperen VW, Veerman G, Noordhuis P, Vermorken JB, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Adv Exp Med Biol. 1991;309A:57-60. doi: 10.1007/978-1-4899-2638-8_12. Adv Exp Med Biol. 1991. PMID: 1789270 No abstract available.

3

Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.

Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):35-41. Semin Oncol. 1995. PMID: 7481843

4

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

Braakhuis BJ, Ruiz van Haperen VW, Boven E, Veerman G, Peters GJ. Braakhuis BJ, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):42-6. Semin Oncol. 1995. PMID: 7481844

5

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 11):72-9. Semin Oncol. 1995. PMID: 7481849

6

DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

Smitskamp-Wilms E, Giaccone G, Pinedo HM, van der Laan BF, Peters GJ. Smitskamp-Wilms E, et al. Among authors: peters gj. Br J Cancer. 1995 Oct;72(4):917-21. doi: 10.1038/bjc.1995.433. Br J Cancer. 1995. PMID: 7547240 Free PMC article.

7

Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.

Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ. Bergman AM, et al. Among authors: peters gj. Adv Exp Med Biol. 1994;370:139-43. doi: 10.1007/978-1-4615-2584-4_32. Adv Exp Med Biol. 1994. PMID: 7660877 No abstract available.

8

Effect of suramin on adenylate cyclase and protein kinase C.

Lopez-Lopez R, Langeveld CH, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM, Peters GJ. Lopez-Lopez R, et al. Among authors: peters gj. Anticancer Drug Des. 1994 Aug;9(4):279-90. Anticancer Drug Des. 1994. PMID: 7916897

9

Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.

Ruiz van Haperen VW, Veerman G, Boven E, Noordhuis P, Vermorken JB, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Biochem Pharmacol. 1994 Oct 7;48(7):1327-39. doi: 10.1016/0006-2952(94)90554-1. Biochem Pharmacol. 1994. PMID: 7945430

10

New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.

Ruiz van Haperen VW, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Pharm World Sci. 1994 Apr 15;16(2):104-12. doi: 10.1007/BF01880661. Pharm World Sci. 1994. PMID: 7980770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters